Compass Therapeutics (CMPX) News Today $4.07 +0.17 (+4.36%) Closing price 10/9/2025 04:00 PM EasternExtended Trading$4.00 -0.07 (-1.62%) As of 05:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Compass Therapeutics Up Today?Toggle Visibility of Why Is Compass Therapeutics Up Today?Compass Therapeutics, Inc. (NASDAQ:CMPX) shares rose today after a series of analyst updates and ratings confirmations. Positive Sentiment: Lifesci Capital reiterated its “Outperform” rating and $10.00 price target, forecasting consistent quarterly EPS of ($0.12) for Q1–Q4 2026 and FY 2026 EPS of ($0.49), alongside detailed estimates for Q3/Q4 2025 and FY 2025. Research Note Neutral Sentiment: Short interest as of October 9 shows 0 shares shorted, yielding a short-interest ratio of 0.0 days based on average volume—indicating negligible bearish positioning. Short Interest Data Negative Sentiment: Weiss Ratings reaffirmed a “sell (d-)” rating on CMPX at a current share price of $3.90, signaling concerns about valuation or near-term performance. Weiss Ratings Investors should weigh the strong analyst optimism and high price target from Lifesci Capital against the lack of short-interest pressure and the sell rating from Weiss before making decisions.Posted 10h agoAI Generated. May Contain Errors. CMPX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Compass Therapeutics' (CMPX) "Sell (D-)" Rating Reiterated at Weiss RatingsOctober 9 at 11:28 PM | marketbeat.comLifeSci Capital Initiates Coverage of Compass Therapeutics (CMPX) with Outperform RecommendationOctober 7 at 6:15 PM | msn.comLifesci Capital Initiates Coverage on Compass Therapeutics (NASDAQ:CMPX)October 7 at 2:39 AM | americanbankingnews.comCompass Therapeutics initiated with an Outperform at LifeSci CapitalOctober 6, 2025 | msn.comCompass Therapeutics (NASDAQ:CMPX) Now Covered by Lifesci CapitalOctober 6, 2025 | marketbeat.comCompass Therapeutics management to meet with Piper SandlerOctober 1, 2025 | msn.comGoldman Sachs Group Inc. Sells 156,917 Shares of Compass Therapeutics, Inc. $CMPXSeptember 27, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Rating of "Buy" by BrokeragesSeptember 24, 2025 | marketbeat.comGuggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer PipelineSeptember 11, 2025 | finance.yahoo.comCompass Therapeutics, Inc. (CMPX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comAdage Capital Partners GP L.L.C. Cuts Stock Position in Compass Therapeutics, Inc. $CMPXSeptember 9, 2025 | marketbeat.comAmerican Century Companies Inc. Takes $140,000 Position in Compass Therapeutics, Inc. $CMPXSeptember 9, 2025 | marketbeat.com304,504 Shares in Compass Therapeutics, Inc. $CMPX Purchased by Nuveen LLCSeptember 6, 2025 | marketbeat.comMPM Bioimpact LLC Trims Stock Position in Compass Therapeutics, Inc. $CMPXSeptember 4, 2025 | marketbeat.comBaker BROS. Advisors LP Cuts Stake in Compass Therapeutics, Inc. $CMPXSeptember 4, 2025 | marketbeat.com222,505 Shares in Compass Therapeutics, Inc. $CMPX Bought by Wellington Management Group LLPSeptember 3, 2025 | marketbeat.comPropel Bio Management LLC Acquires New Position in Compass Therapeutics, Inc. $CMPXSeptember 2, 2025 | marketbeat.comPiper Sandler Reaffirms Optimism on Compass Therapeutics (CMPX) Amid Trial UpdateSeptember 2, 2025 | finance.yahoo.comDeutsche Bank AG Purchases Shares of 102,041 Compass Therapeutics, Inc. $CMPXSeptember 1, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Recommendation of "Buy" from AnalystsSeptember 1, 2025 | marketbeat.comCompass Therapeutics to Participate in Upcoming September Investor EventsAugust 26, 2025 | globenewswire.comCompass Therapeutics (CMPX) Rated ‘Outperform’ amid Clinical Pipeline DevelopmentAugust 19, 2025 | insidermonkey.comHC Wainwright Has Negative Outlook of CMPX FY2025 EarningsAugust 16, 2025 | marketbeat.comEquities Analysts Offer Predictions for CMPX FY2025 EarningsAugust 16, 2025 | marketbeat.comCompass Therapeutics Announces Public Offering to Raise $112.5MAugust 14, 2025 | msn.comWedbush Issues Negative Estimate for CMPX EarningsAugust 14, 2025 | marketbeat.comCompass Therapeutics 33.3M share Spot Secondary priced at $3.00August 13, 2025 | msn.comCompass Therapeutics' (CMPX) "Buy" Rating Reaffirmed at D. Boral CapitalAugust 13, 2025 | marketbeat.comGuggenheim Issues Positive Forecast for Compass Therapeutics (NASDAQ:CMPX) Stock PriceAugust 13, 2025 | marketbeat.comWedbush Equities Analysts Reduce Earnings Estimates for CMPXAugust 13, 2025 | marketbeat.comCompass Therapeutics Announces Pricing of Upsized $120 Million Public OfferingAugust 12, 2025 | globenewswire.comCompass Therapeutics price target raised to $12 from $10 at GuggenheimAugust 12, 2025 | msn.comCompass Therapeutics Announces Proposed Public OfferingAugust 12, 2025 | globenewswire.comCompass Therapeutics (NASDAQ:CMPX) Posts Earnings Results, Misses Estimates By $0.01 EPSAugust 12, 2025 | marketbeat.comCompass Therapeutics Faces Financial Risks Amid Global Economic Uncertainty and Trade TensionsAugust 12, 2025 | msn.comCompass Therapeutics rises after pipeline updatesAugust 11, 2025 | msn.comCompass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate UpdateAugust 11, 2025 | globenewswire.comCompass Therapeutics to Present Second Quarter Financial Results and Provide Business Update on August 11, 2025August 8, 2025 | globenewswire.comCompass Therapeutics (CMPX) Expected to Announce Earnings on MondayAugust 5, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of "Buy" from AnalystsAugust 5, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Buy" by BrokeragesJuly 11, 2025 | marketbeat.comCompass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Raymond James FinancialJuly 1, 2025 | marketbeat.comCMPX Compass Therapeutics, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comSG Americas Securities LLC Buys 545,767 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX)June 16, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Recommendation of "Buy" by AnalystsJune 16, 2025 | marketbeat.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLCJune 15, 2025 | marketbeat.comInsider Buying: Compass Therapeutics, Inc. (NASDAQ:CMPX) CEO Buys 10,000 Shares of StockMay 29, 2025 | marketbeat.comCompass Therapeutics to Participate in the Jefferies Global Healthcare ConferenceMay 28, 2025 | globenewswire.comCompass Therapeutics, Inc. (NASDAQ:CMPX) CEO Thomas J. Schuetz Purchases 10,000 SharesMay 28, 2025 | insidertrades.comCompass Therapeutics, Inc. (NASDAQ:CMPX) Receives Average Rating of "Buy" from BrokeragesMay 24, 2025 | marketbeat.com Get Compass Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CMPX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CMPX Media Mentions By Week CMPX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMPX News Sentiment▼0.960.77▲Average Medical News Sentiment CMPX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMPX Articles This Week▼163▲CMPX Articles Average Week Get the Latest News and Ratings for CMPX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Compass Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OCUL News ANIP News VERA News TWST News DYN News APGE News COGT News TLRY News ABCL News IMCR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMPX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
